ICON Selected by Pfizer as a Global Strategic Partner for Clinical Research and Development
26 May 2011 | By ICON plc
ICON plc has announced a strategic partnership with Pfizer Inc...
List view / Grid view
News
Data supports efficacy of XIAPEX® (collagenase clostridium histolyticum)
26 May 2011 | By red healthcare communications
Data presented for the first time at the annual congress of the FESSH, further supports the role of XIAPEX®...
Tecan offers complete automation for cell-based screening
26 May 2011 | By kdm communications limited
Tecan has launched Tecan Sterile purity disposable tips for the Freedom EVO® liquid handling (LiHa) arm...
ASCO, EORTC, ESMO, INCA and OECI endorse the 3rd WIN Symposium 6-8 July 2011
26 May 2011 | By kdm communications limited
The 3rd WIN Symposium to be held in Paris 6 - 8 July...
Sage-N Research SORCERER platform implemented by the University at Buffalo
25 May 2011 | By The Scott Partnership
Sage-N Research, Inc., announced that the State University of New York has chosen the Sage-N Research SORCERER platform...
StarDrop’s glowing molecule provides visual link between chemical structure and predicted toxicities
25 May 2011 | By The Scott Partnership
Optibrium, announce a range of models to help predict the toxicity of new compounds...
Thermo Fisher Scientific helps optimise productivity of bioequivalence studies and regulatory compliance
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that International Pharmaceutical Research Center (IPRC) has implemented Thermo Scientific Watson LIMS (laboratory information management system) to improve productivity of its Phase I clinical trials unit while enabling compliance with current regulatory requirements.
Tecan’s new Infinite® M1000 – the future of microplate detection has just arrived
24 May 2011 | By kdm communications limited
Tecan has recently updated its Infinite M1000 high-end multimode microplate reader with new features...
AstraZeneca signs agreement in Japan with Daiichi Sankyo
24 May 2011 | By AstraZeneca
AstraZeneca signs agreement with Daiichi Sankyo for denosumab for the treatment of bone disorders...
Abbott completes submission of new molecular test
23 May 2011 | By Abbott
Abbott announced it filed premarket approval applications for a new molecular diagnostic test...
Aesica to increase presence in Asia
23 May 2011 | By Velvet Communications
Aesica Pharmaceuticals has announced the promotion of Joe Zou to manage regional sales across Asia...
Lab21 acquires molecular diagnostics company Myconostica Ltd
23 May 2011 | By College Hill
Lab21 Limited, has announced that it has acquired Myconostica Ltd...
Preventing prostate cancer cells from ‘bodybuilding’ gives new treatment hope
20 May 2011 | By Cancer Research UK
Cancer Research scientists discover that stopping prostate cancer cells ‘bulking up’ with nutrients reduces spread of the disease...
ELIQUIS® (apixaban) approved in Europe for preventing venous thromboembolism
20 May 2011 | By Bristol-Myers Squibb Company
The European Commission has approved ELIQUIS® in the 27 countries of the EU...
GSK and Human Genome Sciences receive positive opinion in Europe from the CHMP for Benlysta® (belimumab)
20 May 2011 | By GlaxoSmithKline
The CHMP has issued a positive opinion, recommending marketing authorisation for Benlysta® (belimumab)...
